213 related articles for article (PubMed ID: 29133571)
1. Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
Henning LN; Carpenter S; Stark GV; Serbina NV
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133571
[TBL] [Abstract][Full Text] [Related]
2. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.
Mytle N; Hopkins RJ; Malkevich NV; Basu S; Meister GT; Sanford DC; Comer JE; Van Zandt KE; Al-Ibrahim M; Kramer WG; Howard C; Daczkowski N; Chakrabarti AC; Ionin B; Nabors GS; Skiadopoulos MH
Antimicrob Agents Chemother; 2013 Nov; 57(11):5684-92. PubMed ID: 23979731
[TBL] [Abstract][Full Text] [Related]
4. Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.
Corey A; Migone TS; Bolmer S; Fiscella M; Ward C; Chen C; Meister G
Toxins (Basel); 2013 Jan; 5(1):120-38. PubMed ID: 23344456
[TBL] [Abstract][Full Text] [Related]
5. Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity.
Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; O'Connor E; Gonzales N; Mondick J; French J; Stark GV; Fisher AC; Casey LS; Serbina NV
Antimicrob Agents Chemother; 2016 Oct; 60(10):5787-95. PubMed ID: 27431222
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
[TBL] [Abstract][Full Text] [Related]
7. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
[TBL] [Abstract][Full Text] [Related]
8. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
[TBL] [Abstract][Full Text] [Related]
10. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
[TBL] [Abstract][Full Text] [Related]
13. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
[TBL] [Abstract][Full Text] [Related]
14. Obiltoxaximab: First Global Approval.
Greig SL
Drugs; 2016 May; 76(7):823-30. PubMed ID: 27085536
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.
Peterson JW; Comer JE; Noffsinger DM; Wenglikowski A; Walberg KG; Chatuev BM; Chopra AK; Stanberry LR; Kang AS; Scholz WW; Sircar J
Infect Immun; 2006 Feb; 74(2):1016-24. PubMed ID: 16428748
[TBL] [Abstract][Full Text] [Related]
16. Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
Leffel EK; Bourdage JS; Williamson ED; Duchars M; Fuerst TR; Fusco PC
Clin Vaccine Immunol; 2012 Aug; 19(8):1158-64. PubMed ID: 22695155
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.
Krishnan V; Andersen BH; Shoemaker C; Sivko GS; Tordoff KP; Stark GV; Zhang J; Feng T; Duchars M; Roberts MS
Clin Vaccine Immunol; 2015 Apr; 22(4):430-9. PubMed ID: 25673303
[TBL] [Abstract][Full Text] [Related]
18. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.
Grossman TH; Anderson MS; Drabek L; Gooldy M; Heine HS; Henning LN; Lin W; Newman JV; Nevarez R; Siefkas-Patterson K; Radcliff AK; Sutcliffe JA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784679
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization and evaluation of protective efficacy of EA752-862 monoclonal antibody against B. anthracis vegetative cell and spores.
Majumder S; Das S; Kingston J; Shivakiran MS; Batra HV; Somani VK; Bhatnagar R
Med Microbiol Immunol; 2020 Apr; 209(2):125-137. PubMed ID: 31811379
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.
Kammanadiminti S; Patnaikuni RK; Comer J; Meister G; Sinclair C; Kodihalli S
PLoS One; 2014; 9(9):e106393. PubMed ID: 25226075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
